Literature DB >> 29467997

Investigation of Class I, II, and III Integrons Among Acinetobacter Baumannii Isolates from Hospitalized Patients in Isfahan, Iran.

Mehrdad Halaji1, Aliakbar Rezaei1, Mehrdad Zalipoor1, Jamshid Faghri1.   

Abstract

OBJECTIVES: This study aimed to determine the prevalence of class I, II, and III integrons among clinical Acinetobacter baumannii isolates collected from hospitalized patients.
METHODS: This cross-sectional study was conducted at two teaching hospitals in Isfahan, Iran, from October 2015 to October 2016. A total of 147 non-duplicate A. baumannii isolates were collected from clinical specimens and identified as A. baumannii using standard microbiological methods and confirmed by genotyping. Antimicrobial susceptibility was determined using disc diffusion method, and the presence of integron genes was performed using the polymerase chain reaction.
RESULTS: Out of 147 confirmed A. baumannii isolates, 97.3% of isolates were extensive drug-resistant (XDR) and 2.7% were multidrug-resistant (MDR). Class I and II integrons were detected in 63.9% and 78.2% of the A. baumannii, respectively. Class III integron was not detected in any of the isolates.
CONCLUSION: Our results show a high prevalence of classes I and II integrons which may play a key role in the acquisition of MDR and XDR phenotype among A. baumannii isolates in our region. Therefore, use of appropriate infection control in clinical settings and implementation of treatment strategies is necessary for our hospitals.

Entities:  

Keywords:  Acinetobacter baumannii; Drug Resistance; Integrons

Year:  2018        PMID: 29467997      PMCID: PMC5798801          DOI: 10.5001/omj.2018.07

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  25 in total

Review 1.  Integrons: past, present, and future.

Authors:  Michael R Gillings
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

2.  Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain.

Authors:  Elisabete Machado; Rafael Cantón; Fernando Baquero; Juan-Carlos Galán; Azucena Rollán; Luísa Peixe; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.

Authors:  S Jasemi; M Douraghi; H Adibhesami; H Zeraati; M Rahbar; M A Boroumand; A Aliramezani; S Ghourchian; M Mohammadzadeh
Journal:  Lett Appl Microbiol       Date:  2016-11-02       Impact factor: 2.858

4.  High prevalence of extensively drug-resistant and metallo beta-lactamase-producing clinical Acinetobacter baumannii in Iran.

Authors:  Hossein Maspi; Hamideh Mahmoodzadeh Hosseini; Mohsen Amin; Abbas Ali Imani Fooladi
Journal:  Microb Pathog       Date:  2016-07-20       Impact factor: 3.738

5.  Detection and characterization of class 1 integrons among carbapenem-resistant isolates of Acinetobacter spp. in Malaysia.

Authors:  Wong Eng Hwa; Geetha Subramaniam; Parasakthi Navaratnam; Shamala Devi Sekaran
Journal:  J Microbiol Immunol Infect       Date:  2009-02       Impact factor: 4.399

Review 6.  Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria.

Authors:  P M Bennett
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

7.  Acquired antibiotic resistance genes: an overview.

Authors:  Angela H A M van Hoek; Dik Mevius; Beatriz Guerra; Peter Mullany; Adam Paul Roberts; Henk J M Aarts
Journal:  Front Microbiol       Date:  2011-09-28       Impact factor: 5.640

8.  Epidemiological characterizations of class 1 integrons from multidrug-resistant acinetobacter isolates in Daejeon, Korea.

Authors:  Ji Youn Sung; Sun Hoe Koo; Semi Kim; Kye Chul Kwon
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

9.  Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: is there an association?

Authors:  Sepideh Kamalbeik; Haleh Talaie; Arezou Mahdavinejad; Abdollah Karimi; Alireza Salimi
Journal:  Korean J Anesthesiol       Date:  2014-04-28

10.  Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections.

Authors:  Zahra Shamsizadeh; Mahnaz Nikaeen; Bahram Nasr Esfahani; Seyed Hamed Mirhoseini; Maryam Hatamzadeh; Akbar Hassanzadeh
Journal:  Environ Health Prev Med       Date:  2017-05-08       Impact factor: 3.674

View more
  9 in total

1.  Genotyping and molecular characterization of clinical Acinetobacter baumannii isolates from a single hospital in Southwestern Iran.

Authors:  Ahmad Farajzadeh Sheikh; Mohammad Savari; Effat Abbasi Montazeri; Saeed Khoshnood
Journal:  Pathog Glob Health       Date:  2020-06-19       Impact factor: 2.894

Review 2.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

3.  Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran.

Authors:  Jamshid Faghri; Samereh Nouri; Saba Jalalifar; Mehrdad Zalipoor; Mehrdad Halaji
Journal:  BMC Res Notes       Date:  2018-11-12

4.  Molecular epidemiology of colistin-resistant Pseudomonas aeruginosa producing NDM-1 from hospitalized patients in Iran.

Authors:  Ahmad Farajzadeh Sheikh; Mojtaba Shahin; Leili Shokoohizadeh; Mehrdad Halaji; Fereshteh Shahcheraghi; Fahimeh Ghanbari
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

5.  Antibiotic Resistance Pattern of Acinetobacter baumannii Strains: A Retrospective Study from Oman.

Authors:  Mohan B Sannathimmappa; Vinod Nambiar; Rajeev Aravindakshan
Journal:  Saudi J Med Med Sci       Date:  2021-09-04

6.  Distribution and Molecular Characterization of Functional Class 2 Integrons in Clinical Proteus mirabilis Isolates.

Authors:  Wenjun Lu; Quedan Qiu; Keda Chen; Rongqing Zhao; Qingcao Li; Qiaoping Wu
Journal:  Infect Drug Resist       Date:  2022-02-16       Impact factor: 4.003

7.  The Resistome of ESKAPEE Pathogens in Untreated and Treated Wastewater: A Polish Case Study.

Authors:  Jakub Hubeny; Ewa Korzeniewska; Sławomir Ciesielski; Grażyna Płaza; Monika Harnisz
Journal:  Biomolecules       Date:  2022-08-21

8.  Prevalence of class 1 integron in Escherichia coli isolated from animal sources in Iran: a systematic review and meta-analysis.

Authors:  Maryam Karimi Dehkordi; Mehrdad Halaji; Samereh Nouri
Journal:  Trop Med Health       Date:  2020-04-07

9.  Prevalence of Integrons and Antibiotic Resistance Pattern in Acinetobacter baumannii Isolated from Clinical Samples of Iranian Patients: A Systematic Review and Meta-analysis.

Authors:  Mehran Ghazalibina; Hamed Mortazavi; Mahtab Babadi; Mohammadreza Rahimi; Azad Khaledi; Manouchehr Teymouri; Ehsan Saburi
Journal:  Ethiop J Health Sci       Date:  2019-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.